Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods and compositions comprising a KRASG12C inhibitor and a PD-L1 binding antagonist for treating lung cancer

Methods and compositions comprising a KRASG12C inhibitor and a PD-L1 binding antagonist for treating lung cancer

US Patent 12171763 · Granted Dec 24, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and compositions comprising a KRasG12C inhibitor and a VEGF inhibitor fo2025
Methods and compositions comprising a KRasG12C inhibitor and a VEGF inhibitor fo2025
Methods and compositions comprising a KRasG12C inhibitor and a VEGF inhibitor fo2025
Methods and compositions comprising a KRasG12C inhibitor and a VEGF inhibitor fo2025
Methods and compositions comprising a KRasG12C inhibitor and a VEGF inhibitor fo2025
Methods and compositions comprising a KRasG12C inhibitor and a VEGF inhibitor fo2025
Treatment of cancer using combination therapies comprising GDC-6036 and GDC-00772025
Treatment of cancer using combination therapies comprising GDC-6036 and GDC-00772025
Treatment of cancer using combination therapies comprising GDC-6036 and GDC-00772025
Therapeutic compounds and methods of use2025
Pyrazolo compounds and methods of use thereof2024
Methods and compositions comprising a KRasG12C inhibitor and a VEGF inhibitor fo2024